Tough Q1 In US For Glenmark, Eyes on Ryaltris Debut, Flovent Rival Filing

Teva Believed To Be Sole Other Flovent ANDA Filer

Glenmark readies launches amid challenging US environment • Source: Shutterstock

More from Business

More from Generics Bulletin